FindTrial
Sign In

Efficacy and safety of macrolide therapy for bronchiectasis; a systematic review and meta-analysis

Efficacy and safety of macrolide therapy for bronchiectasis; a systematic review and meta-analysis - Efficacy and safety of macrolide therapy for bronchiectasis; a systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050821
Enrollment
500
Registered
2023-04-12
Start date
2023-04-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

None listed

Sponsors

The University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with bronchiectasis

Exclusion criteria

Exclusion criteria: cystic fibrosis bronchiectasis

Design outcomes

Primary

MeasureTime frame
Exacerbation requiring hospitalization—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactNatsuki Nakagawa

The University of Tokyo Hospital Department of pulmonary medicine

nnakagawa-tky@umin.ac.jp0338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026